Market Watch: Soleno Therapeutics Inc (SLNO)’s Noteworthy Gain, Closing at 75.02

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

As of close of business last night, Soleno Therapeutics Inc’s stock clocked out at $75.02, up 0.21% from its previous closing price of $74.86. In other words, the price has increased by $0.21 from its previous closing price. On the day, 0.59 million shares were traded. SLNO stock price reached its highest trading level at $75.96 during the session, while it also had its lowest trading level at $72.5.

Ratios:

To gain a deeper understanding of SLNO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.68 and its Current Ratio is at 15.68. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.

On December 02, 2024, Stifel reiterated its Buy ratingand also kept the price unchanged to $74.

Robert W. Baird reiterated its Outperform rating for the stock on December 02, 2024, and also maintained the target price at $72.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Hirano Patricia C sold 3,782 shares for $70.11 per share. The transaction valued at 265,156 led to the insider holds 27,036 shares of the business.

PATRICIA HIRANO bought 3,782 shares of SLNO for $265,156 on Apr 01 ’25. On Mar 28 ’25, another insider, Pauls Matthew, who serves as the Director of the company, sold 5,937 shares for $71.55 each. As a result, the insider received 424,797 and left with 6,500 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLNO now has a Market Capitalization of 3744120576 and an Enterprise Value of 3201603072.

Stock Price History:

The Beta on a monthly basis for SLNO is -2.67, which has changed by 0.6626773 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, SLNO has reached a high of $76.56, while it has fallen to a 52-week low of $36.93. The 50-Day Moving Average of the stock is 28.04%, while the 200-Day Moving Average is calculated to be 44.15%.

Shares Statistics:

It appears that SLNO traded 1.25M shares on average per day over the past three months and 917690 shares per day over the past ten days. A total of 45.70M shares are outstanding, with a floating share count of 39.61M. Insiders hold about 20.63% of the company’s shares, while institutions hold 85.15% stake in the company. Shares short for SLNO as of 1744675200 were 5010515 with a Short Ratio of 4.02, compared to 1741910400 on 4987722. Therefore, it implies a Short% of Shares Outstanding of 5010515 and a Short% of Float of 11.57.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Revenue Estimates

Based on 7 analysts’ estimates, the company’s revenue will be $257.34M in the next fiscal year. The high estimate is $376M and the low estimate is $130.03M.

Most Popular